Diagnosis of myocardial infarction and myocardial viability using contrast-enhanced magnetic resonance imaging;Infarkt- und vitalitätsdiagnostik mittels kontrastverstärkter magnetresonanztomographie

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 23, 2002, Pages 1264-1271

  Mahrholdt, H ^a   Wagner, A ^a   Geissler, A ^a   Sechtem, Udo ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

DIASTOLE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; SYSTOLE; TISSUE SURVIVAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037036252     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-32103     Document Type: Review

References (53)

1. Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients
2. MRI screening in acute chest pain patients
3. Chronic myocardial infarction: Assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile SPECT
4. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability
5. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability
6. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?
7. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery
8. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function
9. Reperfused and non-reperfused myocardial infarction: Diagnostic potential of Gd-DTPA-enhanced MR imaging
10. Segmented turboFLASH: Method for breath-hold MR imaging of the liver with flexible contrast
11. Contrast-enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing
12. Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique
13. Overestimation of infarct size by quantitative two-dimensional echocardiography: The role of tethering and of analytic procedures
14. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations
15. Survival in medically treated coronary artery disease
16. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging
17. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure
18. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts
19. Prognosis after initial myocardial infarction: The Framingham study
20. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study
21. Assessing the myocardium after attempted reperfusion: Should we bother?
22. Relationhip of MR1 delayed contrast enhancement to irreversible injury, infarct age, and contractile function
23. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction
24. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease
25. Relaxation of water protons in the intra- and extracellular regions of blood containing Gd(DTPA)
26. Two-dimensional echocardiography and infarct size: Relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog
27. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms
28. Contractile reserve of dysfunctional myocardium after revascularization: A dobutamine stress echocardiography study
29. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings
30. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA
31. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality
32. Survival of medically treated patients in the coronary artery surgery study (CASS) registry
33. Determination of infarct size of acute myocardial infarction in dogs by magnetic resonance imaging and gadolinium-DTPA: Comparison with indium-111 antimyosin imaging
34. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography
35. Relations between 2-dimensional echocardiographic wall thickening abnormalities, myocardial infarct size and coronary risk area in normal and hypertrophied myocardium in dogs
36. Magnetic resonance imaging of acute myocardial infarction: Gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion
37. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: A dobutamine stress echocardiographic study
38. Extracellular space and ionic distribution in rat ventricle
39. Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis
40. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration
41. Myocardial ischemia, hypoxia and infarction
42. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation
43. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome
44. An improved MR imaging technique for the visualization of myocardial infarction
45. The spectrum of coronary heart disease in a community of 30,000. A clinicopathologic study
46. Small cardiac lesions. Fibrosis of papillary muscles and focal cardiac myocytolysis
47. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: A tomographic assessment using two-dimensional echocardiography
48. Diagnostic significance of gadolinium-DTPA (diethylenetriamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic treatment for acute myocardial infarction: Its potential in assessing reperfusion
49. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis
50. Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent
51. Two-dimensional echocardiographic recognition of myocardial injury in man: Comparison with postmortem studies
52. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation
53. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction